Literature DB >> 22235118

Critical role of leucine-valine change in distinct low pH requirements for membrane fusion between two related retrovirus envelopes.

Marceline Côté1, Yi-Min Zheng, Kun Li, Shi-Hua Xiang, Lorraine M Albritton, Shan-Lu Liu.   

Abstract

Many viruses use a pH-dependent pathway for fusion with host cell membrane, the mechanism of which is still poorly understood. Here we report that a subtle leucine (Leu)-valine (Val) change at position 501 in the envelope glycoproteins (Envs) of two related retroviruses, jaagsiekte sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV), is responsible for their distinct low pH requirements for membrane fusion and infection. The Leu and Val residues are predicted to reside within the C-terminal heptad repeat (HR2) region of JSRV and ENTV Envs, particularly proximal to the hairpin turn of the putative six-helix bundle (6HB). Substitution of the JSRV Leu with a Val blocked the Env-mediated membrane fusion at pH 5.0, whereas replacement of the ENTV Val with a Leu rendered the ENTV Env capable of fusing at pH 5.0. A Leu-Val change has no apparent effect on the stability of native Env, but appears to stabilize an intermediate induced by receptor binding. These results are consistent with the existence of at least two metastable conformations of these viral glycoproteins, the native prefusion conformation and a receptor-induced metastable intermediate. Collectively, this work represents an interesting perhaps unique example whereby a simple Leu-Val change has critical impact on pH-dependent virus fusion and entry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22235118      PMCID: PMC3293530          DOI: 10.1074/jbc.M111.334722

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  The structural biology of type I viral membrane fusion.

Authors:  Peter M Colman; Michael C Lawrence
Journal:  Nat Rev Mol Cell Biol       Date:  2003-04       Impact factor: 94.444

3.  Fusion mutants of the influenza virus hemagglutinin glycoprotein.

Authors:  R S Daniels; J C Downie; A J Hay; M Knossow; J J Skehel; M L Wang; D C Wiley
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

4.  The jaagsiekte sheep retrovirus envelope gene induces transformation of the avian fibroblast cell line DF-1 but does not require a conserved SH2 binding domain.

Authors:  Thomas E Allen; Kate J Sherrill; Sara M Crispell; Matthew R Perrott; Jonathan O Carlson; James C DeMartini
Journal:  J Gen Virol       Date:  2002-11       Impact factor: 3.891

5.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

6.  Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins.

Authors:  Shan-Lu Liu; Fuh-Mei Duh; Michael I Lerman; A Dusty Miller
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 7.  Transformation and oncogenesis by jaagsiekte sheep retrovirus.

Authors:  H Fan; M Palmarini; J C DeMartini
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

8.  Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation.

Authors:  Fabiana A Carneiro; Fausto Stauffer; Carla S Lima; Maria A Juliano; Luiz Juliano; Andrea T Da Poian
Journal:  J Biol Chem       Date:  2003-02-04       Impact factor: 5.157

9.  Mouse mammary tumor virus can mediate cell fusion at reduced pH.

Authors:  S Redmond; G Peters; C Dickson
Journal:  Virology       Date:  1984-03       Impact factor: 3.616

10.  Characterization of enzootic nasal tumour virus of goats: complete sequence and tissue distribution.

Authors:  Aurora Ortín; Christina Cousens; Esmeralda Minguijón; Zoraida Pascual; Maider Pérez de Villarreal; J Michael Sharp; Marcelo De Las Heras
Journal:  J Gen Virol       Date:  2003-08       Impact factor: 3.891

View more
  9 in total

1.  A sorting signal suppresses IFITM1 restriction of viral entry.

Authors:  Kun Li; Rui Jia; Minghua Li; Yi-Min Zheng; Chunhui Miao; Yunfang Yao; Hong-Long Ji; Yunqi Geng; Wentao Qiao; Lorraine M Albritton; Chen Liang; Shan-Lu Liu
Journal:  J Biol Chem       Date:  2014-12-19       Impact factor: 5.157

2.  TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.

Authors:  Minghua Li; Abdul A Waheed; Jingyou Yu; Cong Zeng; Hui-Yu Chen; Yi-Min Zheng; Amin Feizpour; Björn M Reinhard; Suryaram Gummuluru; Steven Lin; Eric O Freed; Shan-Lu Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-06       Impact factor: 11.205

3.  TIM-family proteins inhibit HIV-1 release.

Authors:  Minghua Li; Sherimay D Ablan; Chunhui Miao; Yi-Min Zheng; Matthew S Fuller; Paul D Rennert; Wendy Maury; Marc C Johnson; Eric O Freed; Shan-Lu Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

4.  Enzootic nasal tumor virus type 2 envelope of goats acts as a retroviral oncogene in cell transformation.

Authors:  Naoyoshi Maeda; Yasuo Inoshima; Marcelo De Las Heras; Katsumi Maenaka
Journal:  Virus Genes       Date:  2020-11-05       Impact factor: 2.332

5.  SERINC proteins potentiate antiviral type I IFN production and proinflammatory signaling pathways.

Authors:  Cong Zeng; Abdul A Waheed; Tianliang Li; Jingyou Yu; Yi-Min Zheng; Jacob S Yount; Haitao Wen; Eric O Freed; Shan-Lu Liu
Journal:  Sci Signal       Date:  2021-09-14       Impact factor: 9.517

6.  Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.

Authors:  Manish Tiwari; Divya Mishra
Journal:  J Clin Virol       Date:  2020-05-15       Impact factor: 3.168

7.  Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors.

Authors:  Cong Zeng; John P Evans; Rebecca Pearson; Panke Qu; Yi-Min Zheng; Richard T Robinson; Luanne Hall-Stoodley; Jacob Yount; Sonal Pannu; Rama K Mallampalli; Linda Saif; Eugene Oltz; Gerard Lozanski; Shan-Lu Liu
Journal:  JCI Insight       Date:  2020-11-19

8.  IFITM proteins restrict viral membrane hemifusion.

Authors:  Kun Li; Ruben M Markosyan; Yi-Min Zheng; Ottavia Golfetto; Brittani Bungart; Minghua Li; Shilei Ding; Yuxian He; Chen Liang; James C Lee; Enrico Gratton; Fredric S Cohen; Shan-Lu Liu
Journal:  PLoS Pathog       Date:  2013-01-24       Impact factor: 6.823

9.  IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

Authors:  Jingyou Yu; Minghua Li; Jordan Wilkins; Shilei Ding; Talia H Swartz; Anthony M Esposito; Yi-Min Zheng; Eric O Freed; Chen Liang; Benjamin K Chen; Shan-Lu Liu
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.